Details of the Drug

General Information of Drug (ID: DMBL7FH)

• Drug Name: RTX-240

Indication

Disease Entry	ICD 11	Status	REF
Acute myeloid leukaemia	2A60	Phase 1/2	[1]
Solid tumour/cancer	2A00-2F9Z	Phase 1/2	[1]

• Drug Type: Cell therapy
• Cross-matching ID: TTD ID: D05ZBV
• Repurposed Drugs (RPD): Click to Jump to the Detailed RPD Information of This Drug

References

• [1] ClinicalTrials.gov (NCT04372706) RTX-240 Monotherapy. U.S. National Institutes of Health.